PMID: 945467Jun 24, 1976

Antipsychotic drug doses and neuroleptic/dopamine receptors

Nature
P SeemanK Wong

Abstract

No abstract listed.

References

Dopamine receptors in the brain

Jun 13, 1975·Science·L L Iversen

Dopamine receptor blockade and the neuroleptics, a crystallographic study

Aug 1, 1975·The Journal of Pharmacy and Pharmacology·A S HornO Kennard

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·P SeemanK Wong

Dopamine receptor binding in the corpus striatum of mammalian brain

Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·D R BurtS H Snyder

Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons

Jun 20, 1975·Science·P Seeman, T Lee

Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

Sep 15, 1975·Life Sciences·I CreeseS H Snyder

A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients

Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·A ForsmanR Ohman

Reduction of acetylcholine output from the indirectly stimulated rat diaphragm preparation by some carbamates and phenols

Jul 1, 1972·The Journal of Pharmacy and Pharmacology·P J Forshaw

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

Nov 1, 1972·Clinical Pharmacology and Therapeutics·G SakalisM H Lader

Citations

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

Apr 5, 2012·Archives of General Psychiatry·Oliver D HowesShitij Kapur

Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs

Jul 10, 1999·Synapse·J B AtkinsE J Nestler

Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study

Jul 10, 1999·Synapse·Yoshio MinabeCharles R Ashby

Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study

Sep 27, 2002·Synapse·Thomas P BlackburnCharles R Ashby

D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period

Mar 17, 2001·Synapse·J N Joyce

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

Jan 1, 1990·Synapse·S J O'DellJ F Marshall

Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum

Jan 1, 1992·Synapse·R Rivest, C A Marsden

Quantitative autoradiography of Gpp(NH)p sensitive and insensitive [3H]quinpirole binding sites in the rat brain

Jun 1, 1993·Synapse·D R Gehlert

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

Apr 1, 1994·Synapse·N D VolkowR R MacGregor

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

Jan 1, 1987·Psychopharmacology·L FardeG Sedvall

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET

Jan 1, 1988·Psychopharmacology·L FardeS Stone-Elander

Provocative tests with psychostimulant drugs in schizophrenia

Jan 1, 1987·Psychopharmacology·Jeffrey A LiebermanJ Alvir

BRL 20596, a novel anilide with central dopamine antagonist activity

Jan 1, 1986·Psychopharmacology·W CampbellJ M Semple

Do neuroleptic drugs still have a place in neurological therapy?

Jul 1, 1990·Journal of Neurology·T Klockgether, J Dichgans

Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic

Jan 1, 1983·Psychopharmacology·L Molander, L Borgström

Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment

Jan 1, 1983·Psychopharmacology·T NakaharaA Mukai

Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine

Jan 1, 1983·Psychopharmacology·I M McIntyreM Stanley

Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide

Jan 1, 1980·Psychopharmacology·R M PostF K Goodwin

Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent

Jan 1, 1979·Psychopharmacology·M StanleyB M Cohen

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

Jan 1, 1981·Psychopharmacology·A J CrossF Owen

Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models

Jan 1, 1980·Psychopharmacology·M StanleyD Kleinberg

Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei

Jan 1, 1980·Psychopharmacology·R O MakanjuolaG W Ashcroft

Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues

Jan 1, 1980·Psychopharmacology·John L Waddington, S J Gamble

Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model

Jun 21, 1979·Psychopharmacology·M H JosephJohn L Waddington

Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat

Jan 1, 1981·Psychopharmacology·H LaiA Horita

A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites

Jan 1, 1989·Psychopharmacology·B M CohenC Waternaux

Biochemical and behavioural properties of clozapine

Jan 1, 1989·Psychopharmacology·D M CowardT G White

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Jan 1, 1989·Psychopharmacology·L FardeG Sedvall

The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools

Aug 8, 1979·Psychopharmacology·S E RobinsonF Sulser

Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase

Dec 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·M E GnegyE Costa

Striatal and frontal cortex binding of 11-C-labelled clozapine visualized by positron emission tomography (PET) in drug-free schizophrenics and healthy volunteers

Jan 1, 1989·Psychopharmacology·T LundbergB Långström

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

Jan 1, 1988·Psychopharmacology·L FardeG Sedvall

Calmodulin in brain of schizophrenics

Jun 1, 1980·Neurochemical Research·F Vargas, A Guidotti

Calcium channel activity in rat brain synaptosomes: effects of neuroleptics and other factors regulating phosphorylation and transmitter release

Jan 1, 1984·Neurochemical Research·W Hoss, M Formaniak

Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride

Jan 1, 1988·Journal of Neural Transmission·H HallG Sedvall

Sexual behavior of the male schizophrenic: the impact of illness and medications

Oct 1, 1981·Archives of Sexual Behavior·J N NestorosT Ban

The biology of schizophrenia

Nov 15, 1982·Experientia·T J Crow

The pharmacological and biochemical basis of neuroleptic treatment in schizophrenia

Jun 25, 1982·Pharmaceutisch Weekblad. Scientific Edition·C J Niemegeers, J E Leysen

NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors

Jan 1, 1991·Psychopharmacology·H HallL Farde

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

Jan 1, 1992·Psychopharmacology·A L NordströmC Halldin

Influence of rate of administration of raclopride on akathisia and prolactin response

Mar 1, 1994·Psychopharmacology·G Movin-OsswaldL Farde

Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride

Jan 1, 1993·Psychopharmacology·C J BenchR S Frackowiak

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

Jan 1, 1992·Psychopharmacology·D E Casey

The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

Jan 1, 1993·Psychopharmacology·J N Joyce

Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study

Jan 1, 1995·Psychopharmacology·G F BusattoR W Kerwin

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain

Mar 1, 1996·Psychopharmacology·P HertelT H Svensson

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats

Mar 1, 1996·Psychopharmacology·Frank P BymasterR W Fuller

The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography

Mar 1, 1996·Psychopharmacology·C J BenchR S Frackowiak

Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man

May 1, 1995·Psychopharmacology·P KarlssonM Sloth-Nielsen

The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys

Oct 1, 1995·Psychopharmacology·D E Casey

Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man

Oct 1, 1995·Psychopharmacology·P KarlssonL Farde

Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients

Oct 1, 1995·Psychopharmacology·P KarlssonFrits-axel Wiesel

Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats

Nov 1, 1995·Psychopharmacology·N R SwerdlowM A Geyer

Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia

Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·H IchinoseT Nagatsu

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

Jan 1, 1993·Psychopharmacology·S NybergB Eriksson

Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors

Jan 1, 1992·Molecular Neurobiology·T A ReaderK M Dewar

Gene-environment interplay in schizopsychotic disorders

Jun 9, 2004·Neurotoxicity Research·Tomas PalomoRrichard J Beninger

Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor

Jun 9, 2004·Neurotoxicity Research·L LericheP Sokoloff

Antipsychotic-induced oxidative stress in rat brain

Mar 28, 2008·Neurotoxicity Research·Márcio Rodrigo MartinsJoão Quevedo

Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

Feb 15, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·G VauquelinP Seeman

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration

Mar 10, 2004·Psychopharmacology·Mirjam TalvikL Farde

The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice

Jan 20, 2007·Psychopharmacology·Kim FejginDaniel Klamer

Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning

Jul 14, 2010·Psychopharmacology·Ming LiGang Hu

Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography

Aug 8, 2012·Psychopharmacology·Shunsuke NakazawaHirotaka Onoe

Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

Jul 5, 2005·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller

A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia

Apr 13, 2013·Cell and Tissue Research·Benjamin K Yee, Philipp Singer

Historical evolution of the neurotransmission concept

Apr 8, 2009·Journal of Neural Transmission·Francisco López-Muñoz, Cecilio Alamo

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia

Aug 16, 2005·Current Psychiatry Reports·Thomas W Weickert, Terry E Goldberg

Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress

Feb 10, 2010·Neurotoxicity Research·Anthony A Grace

Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity

Aug 15, 1983·Biochemical Pharmacology·M W Goosey, N S Doggett

A mechanism for the involvement of colocalized neuropeptides in the actions of antipsychotic drugs

Jul 1, 1989·Biological Psychiatry·R F Gariano, P M Groves

Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist

Feb 15, 1989·Biological Psychiatry·H KanedaK Tanimoto

A. E. Bennett Award paper. Expression of the dopamine D2 receptor gene in brain

Nov 15, 1991·Biological Psychiatry·J H Meador-Woodruff, A Mansour

Calcium channel blockade interacts with a neuroleptic to attenuate the conditioning of amphetamine's behavioral effects in the rat

Jun 1, 1992·Biological Psychiatry·S L DiLullo, M T Martin-Iverson

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study

Apr 1, 1992·Biological Psychiatry·H Silver, A Nassar

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

Feb 15, 1993·Biological Psychiatry·A L NordströmG Uppfeldt

Acute effects of neuroleptics on unmedicated schizophrenic patients and controls

Aug 1, 1993·Biological Psychiatry·A L MillerJ Castiglioni

Clozapine and seizures

Apr 1, 1995·Biological Psychiatry·D Denney, J R Stevens

Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol

Nov 18, 1977·Brain Research·J Z FieldsH I Yamamura

The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain

Jul 8, 1977·Brain Research·V HölltA Herz

An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain

Mar 9, 1979·Brain Research·K G Lloyd, S Dreksler

Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites

Jan 26, 1979·Brain Research·D R Howlett, S R Nahorski

Sodium-dependent interaction of benzamides with dopamine receptors

Sep 29, 1980·Brain Research·E StefaniniP F Spano

Peptides, the limbic lobe and schizophrenia

Dec 12, 1983·Brain Research·G W RobertsJ M Polak

Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor

May 6, 1985·Brain Research·N FujitaH Yoshida

Dopamine-stimulated adenylate cyclase and tyrosine hydroxylase in diabetic rat retina

Jun 24, 1985·Brain Research·F K NorthingtonS P Banerjee

Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons

Jul 14, 1987·Brain Research·T H HandR Y Wang

Monoclonal antibodies to study the brain in schizophrenia

Oct 23, 1989·Brain Research·W G HonerP Davies

Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study

Mar 22, 1991·Brain Research·R RivestC A Marsden

Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes

Apr 19, 1991·Brain Research·C F Saller, L D Kreamer

The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo

Mar 6, 1992·Brain Research·J Ichikawa, H Y Meltzer

The effect of antipsychotic drugs and their clinically inactive analogs on dopamine metabolism

Aug 15, 1977·European Journal of Pharmacology·M Stanley, S Wilk

Tolerance of haloperidol catalepsy

Feb 7, 1977·European Journal of Pharmacology·C Ezrin-Waters, P Seeman

On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs

Mar 21, 1977·European Journal of Pharmacology·B H WesterinkH M Van Praag

Perlapine and dopamine metabolism: prediction of antipsychotic efficacy

Jan 7, 1977·European Journal of Pharmacology·S Wilk, M Stanley

Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions

Dec 7, 1979·European Journal of Pharmacology·L C MurrinM J Kuhar

Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors

Nov 16, 1979·European Journal of Pharmacology·H TachizawaM Sano

Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors

Apr 15, 1979·European Journal of Pharmacology·P SeemanJ A Poat

Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics

Apr 15, 1979·European Journal of Pharmacology·P Muller, P Seeman

Dopaminergic antagonism and catalepsy in the developing rat

Feb 15, 1979·European Journal of Pharmacology·L A BaezC Shanklin

Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administration

Oct 31, 1980·European Journal of Pharmacology·John L Waddington, S J Gamble

The effects of long-term ethanol on brain receptors for dopamine, acetylcholine, serotonin and noradrenaline

Jul 11, 1980·European Journal of Pharmacology·P MullerP Seeman

Assay for soluble dopamine receptors by the precipitation method

Aug 27, 1981·European Journal of Pharmacology·B ChanP Seeman

Irreversible blockade of striatal dopamine receptors in vivo by a derivative of alpha-flupenthixol

Feb 5, 1982·European Journal of Pharmacology·D I SchusterR B Murphy

Comparison of soluble dopamine D2-receptors from three species

Mar 26, 1982·European Journal of Pharmacology·Bertha K MadrasP Seeman

Behavioural and biochemical changes following chronic administration of L-dopa to rats

Apr 23, 1982·European Journal of Pharmacology·C PycockC O'Shaughnessy

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

Aug 17, 1984·European Journal of Pharmacology·E Richelson, A Nelson

Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum

Jul 17, 1985·European Journal of Pharmacology·R G MacKenzie, M J Zigmond

Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain

May 8, 1985·European Journal of Pharmacology·H HallL Gawell

Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding

Jun 24, 1986·European Journal of Pharmacology·P A HalsS G Dahl

Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity

Oct 27, 1987·European Journal of Pharmacology·D P O'Brien, F J White

Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions

Jun 12, 1987·European Journal of Pharmacology·M MemoP F Spano

Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride

Jun 12, 1987·European Journal of Pharmacology·F FillouxT M Dawson

Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain

Jan 27, 1988·European Journal of Pharmacology·P H Andersen

Quinine potently blocks single K+ channels activated by dopamine D-2 receptors in rat corpus striatum neurons

May 19, 1989·European Journal of Pharmacology·J E Freedman, F F Weight

Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain

Mar 14, 1989·European Journal of Pharmacology·W H ChangL Tsay

Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand

Aug 16, 1991·European Journal of Pharmacology·H HallI Wedel

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine

Apr 10, 1991·European Journal of Pharmacology·B A EllenbroekA R Cools

The effect of the potential antipsychotic ORG 5222 on local cerebral glucose utilization in freely moving rats

Dec 3, 1991·European Journal of Pharmacology·P RoomJ A Tonnaer

Trifluoperazine inhibition of insulin-induced increase in skeletal muscle glucose uptake

Jun 11, 1993·European Journal of Pharmacology·V GuarnerF Valenzuela

A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors

Jun 24, 1993·European Journal of Pharmacology·A N Gifford, K M Johnson

Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation

Feb 9, 1993·European Journal of Pharmacology·C Marin, T N Chase

Differential visualization of dopamine D2 and D3 receptors in rat brain

Apr 6, 1993·European Journal of Pharmacology·B ParsonsJonathan A Javitch

Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801

Jun 13, 1996·European Journal of Pharmacology·D J Healy, J H Meador-Woodruff

Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain

Oct 17, 1996·European Journal of Pharmacology·B KarolewiczJ Vetulani

Biological markers in mental disorders: post-mortem studies

Jan 1, 1984·Journal of Psychiatric Research·M Rossor

Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain

Nov 1, 1985·Journal of the Neurological Sciences·J De KeyserG Vauquelin

In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists

Oct 15, 1977·Life Sciences·M BaudryJ C Schwartz

Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors

Dec 15, 1977·Life Sciences·P Muller, P Seeman

Selective labeling of pre-synaptic receptors by 3H-dopamine, 3H-apomorphine and 3H-clonidine; labeling of post-synaptic sites by 3H-neuroleptics

Aug 14, 1978·Life Sciences·M TitelerP Seeman

Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities

Aug 14, 1978·Life Sciences·Y Clement-Courmier, R George

The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro

Aug 14, 1978·Life Sciences·J L HowardI A Pullar

A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors

Aug 14, 1978·Life Sciences·H Y MeltzerM Young

3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions

Aug 14, 1978·Life Sciences·L J ThalR Katzman

The tyramines: functionally significant biogenic amines or metabolic accidents?

Aug 21, 1978·Life Sciences·A A Boulton

The effect of varying 3H-spiperone concentration on its binding parameters

Aug 7, 1978·Life Sciences·E J Hartley, P Seeman

Dopamine receptor binding in vivo: the feasibility of autoradiographic studies

Jan 1, 1978·Life Sciences·M J KuharN Klemm

The substituted benzamides--a novel class of dopamine antagonists

Aug 6, 1979·Life Sciences·P Jenner, C D Marsden

Biochemical characterization of the dopaminergic innervation of the rat septum

May 19, 1980·Life Sciences·R ColluA Argiolas

3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland

Feb 25, 1980·Life Sciences·E StefaniniR Collu

Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes

Apr 7, 1980·Life Sciences·G Le FurA Uzan

Glucose potentiates haloperidol-induced catalepsy

Nov 30, 1981·Life Sciences·C F Saller, I J Kopin

Electric convulsive therapy (ECT) increases plasma and red blood cell haloperidol neuroleptic activities

Oct 31, 1983·Life Sciences·A AobaK Hasegawa

The effect of chronic neuroleptic administration on cerebral dopamine receptor function

May 16, 1983·Life Sciences·M N RupniakC D Marsden

Specific in vivo binding of 77Br-brombenperidol in rat brain

Sep 24, 1984·Life Sciences·S M Moerlein, G Stöcklin

Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat

Aug 18, 1986·Life Sciences·J A Piontek, R Y Wang

Dopamine receptor subtype imbalance in schizophrenia

Apr 13, 1987·Life Sciences·E J HessI Creese

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Dec 21, 1987·Life Sciences·L HagenfeldtFrits-axel Wiesel

In vitro evaluation of radioiodinated butyrophenones as radiotracer for dopamine receptor study

Oct 26, 1987·Life Sciences·I NakatsukaA Yokoyama

The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia

Jan 1, 1988·Life Sciences·R M CohenD Pickar

Intraventricular infusion of leupeptin decreases Bmax of the D2 receptor in the striatum of young rats

Jan 1, 1992·Life Sciences·M ShibataK Kitani

Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells

Jan 1, 1994·Life Sciences·S M Farooqui

Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells

Jan 1, 1995·Life Sciences·H C AkunneT A Pugsley

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

Sep 1, 1977·Neuropharmacology·S J PeroutkaS H Snyder

Radioreceptor assay of haloperidol tissue levels in the rat

Jul 1, 1980·Neuropharmacology·B M CohenRoss J Baldessarini

Comparison of the effects of antipsychotic drugs on the schedule-controlled behavior of squirrel monkeys and pigeons

Apr 1, 1983·Neuropharmacology·J E Barrett

Can neuroleptics influence the function of the brain hemispheres asymmetrically?

Jan 1, 1984·Neuropharmacology·J Fritze

Effect of antipsychotic and other classes of drugs on spontaneous locomotor activity and neurotoxicity in mice

Jan 1, 1978·Pharmacology, Biochemistry, and Behavior·J R McLeanLinda L Coughenour

Differential actions of classical and atypical antipsychotic drugs on spontaneous neuronal activity in the amygdaloid complex

Jan 1, 1981·Pharmacology, Biochemistry, and Behavior·G V RebecT R Bashore

Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses

Feb 1, 1981·Pharmacology, Biochemistry, and Behavior·H Kuribara, Shigenori Tadokoro

The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy

Feb 1, 1982·Pharmacology, Biochemistry, and Behavior·J J FeigenbaumH Klawans

Time course of pimozide effects on brain stimulation reward

Apr 1, 1983·Pharmacology, Biochemistry, and Behavior·J Atalay, R A Wise

Lack of potency of metoclopramide's metabolites in various dopaminergic models

Feb 1, 1983·Pharmacology, Biochemistry, and Behavior·M StanleyL R Meyerson

A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs

Sep 1, 1985·Pharmacology, Biochemistry, and Behavior·T Ljungberg, U Ungerstedt

Effect of YM-09151-2, a putative D2 dopamine receptor antagonist, on dopamine metabolism in the striatum of rats

Oct 1, 1989·Pharmacology, Biochemistry, and Behavior·S ShibanokiK Ishikawa

Differential attenuation of water intake and water-rewarded operant responding by repeated administration of haloperidol and SCH 23390 in the rat

Jan 1, 1990·Pharmacology, Biochemistry, and Behavior·T Ljungberg

Similar behavioral and biochemical effects of long-term haloperidol and caerulein treatment in albino mice

Apr 1, 1990·Pharmacology, Biochemistry, and Behavior·E VasarA Lang

Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment

Feb 1, 1995·Pharmacology, Biochemistry, and Behavior·I UshijimaM Yamada

Catalepsy, Fos protein, and dopamine receptor occupancy after long-term haloperidol treatment

Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·H J CoppensJ Korf

Interactions of clozapine with the stimulus effects of DOM and LSD

Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·P A Palumbo, J C Winter

Inhibitory effects of putative dopamine D3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats

Feb 1, 1996·Pharmacology, Biochemistry, and Behavior·M KurashimaT Furukawa

Now we understand antipsychotics?

Nov 17, 1990·Lancet

Multiple dopamine receptors and behavior

Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce

A neural plasticity hypothesis of schizophrenia

Jan 1, 1984·Neuroscience and Biobehavioral Reviews·J L Haracz

Free radical mechanisms in schizophrenia and tardive dyskinesia

Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J L Cadet, L A Kahler

Neurobiological mechanisms controlling aggression: preclinical developments for pharmacotherapeutic interventions

Jan 1, 1994·Neuroscience and Biobehavioral Reviews·K A MiczekJ Tidey

The opioid system in neurologic and psychiatric disorders and in their experimental models

Jan 1, 1990·Pharmacology & Therapeutics·K Gulya

Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs

Jan 1, 1993·Pharmacology & Therapeutics·B A Ellenbroek

Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites

Oct 1, 1979·Psychiatry Research·B M CohenA Aoba

Cerebrospinal fluid hydroxylase cofactor in schizophrenia

Apr 1, 1982·Psychiatry Research·J C GarbuttW M Lovenberg

Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure

Mar 1, 1991·Psychiatry Research·M H Schmidt, T Lee

Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia

Feb 1, 1993·Psychiatry Research·M DavidsonK L Davis

Hyperdopaminergia in schizophreniform psychosis: a chronobiological study

May 1, 1993·Psychiatry Research·M L RaoP Bräunig

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

Dec 1, 1993·Psychiatry Research·L E TuneJ Sapp

PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness

Jul 1, 1990·Trends in Neurosciences·G Sedvall

The advantage of using positron emission tomography in drug research

Jun 1, 1996·Trends in Neurosciences·L Farde

Stereospecific effect of flupenthixol on neuroreceptor gene expression

May 1, 1991·Brain Research. Molecular Brain Research·A De La ConchaH M Gurling

Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary

Apr 1, 1994·Brain Research. Molecular Brain Research·M JaberB Bloch

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex

Sep 5, 1996·Brain Research. Molecular Brain Research·S P DamaskJ H Meador-Woodruff

Dopamine receptors in brain and periphery

Jan 1, 1987·Neurochemistry International·P Seeman, D Grigoriadis

Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology

Mar 1, 1992·Neurochemistry International·P SokoloffJ C Schwartz

Long-term neuroleptic treatments counteract dopamine D2 agonist inhibition of adenylate cyclase but do not affect pertussis toxin ADP-ribosylation in the rat brain

Feb 1, 1996·Neurochemistry International·F OkadaY Nomura

Central D1- and D2-receptor occupancy during antipsychotic drug treatment

Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frits-axel WieselG Sedvall

The psychopharmacology of astroglial cells

Jan 1, 1980·Progress in Neurobiology·F A Henn, S W Henn

The physiology and pharmacology of mammalian basal ganglia

Jan 1, 1980·Progress in Neurobiology·A Dray

Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms

Jan 1, 1982·Progress in Neurobiology·W Schultz

Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs

Jan 1, 1990·Progress in Neurobiology·R MillerR J Beninger

The psychology of perserverative and stereotyped behaviour

Oct 1, 1994·Progress in Neurobiology·R M Ridley

(3)H]haloperidol and [(3)H]spiroperidol receptor binding after striatal injection of kainic acid

Jun 1, 1978·Neuroscience Letters·S GovoniP F Spano

Stimulation of adenosine A2 receptors induces catalepsy

Sep 16, 1991·Neuroscience Letters·S FerréK Fuxe

Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET

Dec 14, 1992·Neuroscience Letters·S M Moerlein, J S Perlmutter

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

Oct 29, 1993·Neuroscience Letters·M Zhang, I Creese

Anti-glutamatergic effects of clozapine

Dec 12, 1993·Neuroscience Letters·T I LidskyS P Banerjee

The pharmacology of sulpiride--a dopamine receptor antagonist

Jan 1, 1982·General Pharmacology·S E O'Connor, R A Brown

The effect of neuroleptic drugs on serum testosterone level in the male rat

Jan 1, 1986·General Pharmacology·A D OkonmahK F Soliman

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence

Jan 1, 1978·Neuroscience·O Hornykiewicz

Adaptive changes in catecholamine receptors in the central nervous system

Jan 1, 1981·Neuroscience·T Reisine

Dopamine receptors in human brain: autoradiographic distribution of D2 sites

Jan 1, 1989·Neuroscience·M CampsJ M Palacios

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

Jan 1, 1991·Neuroscience·Anthony A Grace

Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism

Jan 1, 1992·Neuroscience·R Rivest, C A Marsden

Lateralized interdependence between limbicotemporal and ventrostriatal dopaminergic transmission

Apr 1, 1994·Neuroscience·A Louilot, M Le Moal

Psychoendocrinology and growth hormone: a review

Apr 1, 1978·Psychoneuroendocrinology·G M BrownP G Ettigi

The dopamine hypothesis of schizophrenia revisited

Jan 1, 1979·Psychoneuroendocrinology·D P van Kammen

Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia

Jan 1, 1985·Psychoneuroendocrinology·P MonteleoneL Steardo

Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase

Apr 1, 1988·Brain Research Bulletin·F FillouxJ K Wamsley

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

Sep 1, 1990·Brain Research Bulletin·M A GeyerD L Braff

Possible noradrenergic dysfunction in schizophrenia

Jan 1, 1994·Brain Research Bulletin·K YamamotoM Yoshii

The influence of anterior neostriatal lesions on the behavioural effects of spiroperidol in rats

Jan 1, 1980·Progress in Neuro-psychopharmacology·S P LoweryL A Baez

Solubilized dopamine/neuroleptic receptors (D2-type)

Jan 1, 1981·Progress in Neuro-psychopharmacology·Bertha K MadrasP Seeman

Differential modulation of mouse brain biogenic amines by haloperidol and pimozide: implications in Tourette's syndrome

Jan 1, 1990·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·F S Messiha

Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging

Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes·S M MoerleinM J Welch

Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction

Nov 1, 1988·Schizophrenia Research·B LererA Calev

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

Mar 1, 1991·Schizophrenia Research·Ariel Y DeutchD S Charney

Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals

Sep 1, 1994·Schizophrenia Research·D MalaspinaH A Sackeim

Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro

Dec 15, 1994·European Journal of Pharmacology·A Westlind-DanielssonI Andersson

Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats

Mar 15, 1995·European Journal of Pharmacology·O SchootsH H Van Tol

Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study

Mar 1, 1995·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H HallG Sedvall

Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia

Jun 1, 1994·Psychiatry Research·S VolkB Pflug

Synthesis and autoradiographic localization of the dopamine D-1 agonists [11C]SKF 75670 and [11C]SKF 82957 as potential PET radioligands

Mar 1, 1996·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Jean N DaSilvaS Houle

Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand

Aug 1, 1995·Nuclear Medicine and Biology·S M MoerleinM J Welch

The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP+

Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Donald M N SikazweSeth Y Ablordeppey

Chemoenzymatic synthesis and binding affinity of novel (R)- and (S)-3-aminomethyl-1-tetralones, potential atypical antipsychotics

Jan 27, 2004·Bioorganic & Medicinal Chemistry Letters·Yolanda CaroMaría I Loza

Synthesis and binding affinity of novel 3-aminoethyl-1-tetralones, potential atypical antipsychotics

May 10, 2005·Bioorganic & Medicinal Chemistry Letters·Mario AlvaradoMaría I Loza

What's atypical about atypical antipsychotic drugs?

Mar 17, 2004·Current Opinion in Pharmacology·Herbert Y Meltzer

Schizophrenia and dopamine receptors

Jul 19, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P Seeman

The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia

Jun 26, 2013·Journal of Physiology, Paris·Eiichi Jodo

How antipsychotics work-from receptors to reality

Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Shitij KapurMing Li

Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain

Jun 15, 2005·Pharmacology, Biochemistry, and Behavior·Marilise E BurgerJoão B T Rocha

Half a century of antipsychotics and still a central role for dopamine D2 receptors

Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shitij Kapur, David Mamo

Muscarinic mechanisms of antipsychotic atypicality

Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frank P BymasterDavid L Mckinzie

Serotonin receptors: their key role in drugs to treat schizophrenia

Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJ Ichikawa

Neuroleptic binding to sigma receptors: possible involvement in neuroleptic-induced acute dystonia

May 15, 1997·Biological Psychiatry·A P JeanjeanJ M Maloteaux

Sensitization with clozapine: beyond the dopamine hypothesis

Nov 5, 1997·Biological Psychiatry·J R StevensP Szot

The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia

Nov 5, 1997·Biological Psychiatry·P L MarzellaD L Copolov

Serotonergic basis of antipsychotic drug effects in schizophrenia

Dec 4, 1998·Biological Psychiatry·Jeffrey A LiebermanJ E Kraus

Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?

Feb 25, 1998·Biological Psychiatry·W T CarpenterJ Volavka

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure

Jul 27, 1999·Biological Psychiatry·L D SelemonP S Goldman-Rakic

Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration

Oct 24, 2002·Brain Research·Jennifer Chlan-FourneyXin-Min Li

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

Nov 26, 2002·Brain Research·J IchikawaHerbert Y Meltzer

The dopamine D(4) receptor: one decade of research

Oct 18, 2000·European Journal of Pharmacology·J N OakH H Van Tol

Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy

Oct 24, 2001·European Journal of Pharmacology·S J AlcockA D Crocker

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

Jun 14, 2002·European Journal of Pharmacology·Shaun JordanC Anthony Altar

Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?

Nov 16, 2002·European Journal of Pharmacology·B H Westerink

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

Feb 20, 2003·European Journal of Pharmacology·Hans O Kalkman, Erika Loetscher

Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

Feb 19, 1997·European Journal of Pharmacology·A InoueY Nakata

Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum

Feb 26, 1997·European Journal of Pharmacology·T IshikaneT Koyama

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action

Aug 28, 1998·European Journal of Pharmacology·J M WilsonH H Van Tol

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

Oct 17, 1998·European Journal of Pharmacology·Frank P BymasterAnders Fink-Jensen

The natural history and pathophysiology of treatment resistant schizophrenia

Oct 30, 1998·Journal of Psychiatric Research·B B Sheitman, Jeffrey A Lieberman

In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic

Jul 20, 2002·Life Sciences·Takeo FunakoshiShigeru Okuyama

In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-[2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl] piperidine (NRA0161)

Oct 2, 2002·Life Sciences·Yoshiko SuzukiShigeru Okuyama

Treatment with haloperidol or clozapine causes changes in dopamine receptors but not adenylate cyclase or protein kinase C in the rat forebrain

Jan 1, 1996·Life Sciences·D C WanD L Copolov

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

Jan 1, 1997·Life Sciences·Arvid CarlssonM L Carlsson

Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation

Apr 30, 1999·Neuropharmacology·S BalijepalliV Ravindranath

Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat

Sep 6, 2002·Physiology & Behavior·Karen M TrimbleDavid J King

Sensitivity to ageing of the limbic dopaminergic system: a review

Jan 12, 1999·Mechanisms of Ageing and Development·P BariliF Amenta

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo

Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Vincenzo Di MatteoEnnio Esposito

Antipsychotic-like profile of alstonine

Jun 4, 1998·Pharmacology, Biochemistry, and Behavior·L Costa-CamposE Elisabetsky

Dopamine and schizophrenia

Dec 4, 1976·Lancet·B H Westerink, J Korf

D3 dopamine receptor, behavioral sensitization, and psychosis

Sep 22, 2001·Neuroscience and Biobehavioral Reviews·Neil M RichtandStephen M Strakowski

Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness

Sep 3, 2002·Neuroscience and Biobehavioral Reviews·George R BreeseSheryl S Moy

Schizophrenia: from phenomenology to neurobiology

Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Albert H C Wong, H H Van Tol

Behavioral effects of clozapine and dopamine receptor subtypes

Nov 14, 1997·Neuroscience and Biobehavioral Reviews·S A JosselynR J Beninger

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

Oct 2, 2001·Pharmacology & Therapeutics·J N Joyce

Dopamine receptors--physiological understanding to therapeutic intervention potential

Dec 22, 1999·Pharmacology & Therapeutics·G EmilienS Cragg

An integrated view of pathophysiological models of schizophrenia

Apr 21, 1999·Brain Research. Brain Research Reviews·Gary E DuncanJeffrey A Lieberman

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

Mar 17, 2000·Brain Research. Brain Research Reviews·J C SchwartzP Sokoloff

Glutamate receptor expression in schizophrenic brain

Mar 17, 2000·Brain Research. Brain Research Reviews·J H Meador-Woodruff, D J Healy

Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia

May 15, 2002·Psychiatry Research·Elias K AngelopoulosJohn Tzemos

Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans

Dec 2, 2000·Behavioural Brain Research·J V SalgadoG Sandner

Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum

Jul 1, 1997·Brain Research. Molecular Brain Research·D J Healy, J H Meador-Woodruff

Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study

Oct 23, 1997·Brain Research. Molecular Brain Research·C BranaB Bloch

Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs

Dec 24, 1997·Brain Research. Molecular Brain Research·M A RivaG Racagni

Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary

Jun 24, 1998·Brain Research. Molecular Brain Research·A InoueY Nakata

Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats

Oct 31, 1998·Brain Research. Molecular Brain Research·Z H MengKalpana Merchant

In vivo monitoring of drugs using radiotracer techniques

Mar 4, 2000·Advanced Drug Delivery Reviews·A SaleemP M. Price

EEDQ reduces the striatal neurotensin mRNA response to haloperidol

Jan 1, 1997·Peptides·M R AdamsD M Dorsa

Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics

Feb 27, 2001·Neurochemistry International·S BalijepalliV Ravindranath

Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine

Dec 1, 1996·Neurochemistry International·L W ZhouB Weiss

Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies

Mar 1, 1997·Neurochemistry International·N HuangT A Reader

Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: inverse agonism by D2 receptor antagonists

Aug 22, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·C M BullockQ Y Zhou

Central nervous system receptors in neuropsychiatric disorders

Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·G Kato, T Ban

Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs

Jul 31, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frank I TaraziRoss J Baldessarini

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

Apr 5, 2000·Progress in Neurobiology·O A Andreassen, H A Jørgensen

Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: rotational behaviour

Sep 14, 2000·Neuroscience Letters·A H WongH H Van Tol

Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain

Jul 13, 1999·General Pharmacology·N KawashimaK Tomisawa

A role for presynaptic mechanisms in the actions of nomifensine and haloperidol

Apr 25, 2003·Neuroscience·P A GarrisR M Wightman

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment

Jun 1, 1997·Neuroscience·Frank I TaraziI Creese

Defective inhibition of dream event memory formation: a hypothesized mechanism in the onset and progression of symptoms of schizophrenia

Jul 17, 1998·Brain Research Bulletin·P H Kelly

Kindling with clozapine: behavioral and molecular consequences

Dec 1, 1996·Epilepsy Research·J R StevensP Szot

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

May 10, 2001·Schizophrenia Research·T RasmussenFrank P Bymaster

Effects of the 5HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia

Dec 1, 2001·Schizophrenia Research·I B ChaudhryJ F W Deakin

Brain imaging of schizophrenia--the dopamine hypothesis

Feb 19, 1998·Schizophrenia Research·L Farde

New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up

Feb 19, 1998·Schizophrenia Research·V W LarachR G Torres

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

Feb 16, 1999·Schizophrenia Research·J HietalaR K Salokangas

Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses

Aug 30, 2000·Schizophrenia Research·B ApplebergR Rimón

Use of antipsychotic agents in Spain through 1985-2000

Dec 31, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·Blanca SantamaríaFrancisco J de Abajo

Increased platelet vesicular monoamine transporter density in adult schizophrenia patients

Jul 20, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michal ZuckerMoshe Rehavi

The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity

Aug 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·T OzakiS Yamagami

Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors

Jan 11, 2000·Nuclear Medicine and Biology·B ShiJ Mukherjee

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography

Mar 21, 2001·Drug Discovery Today·E O. AboagyeT Jones

The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis

Nov 1, 1991·Psychological Medicine·D P van Kammen

Adverse effects of anticholinergic medication on positive schizophrenic symptoms

Aug 1, 1983·Psychological Medicine·E C JohnstoneS J Gamble

Schizophrenia and antipsychotic somatic treatment

Oct 1, 1996·International Journal of Technology Assessment in Health Care·Leif H Lindström, I M Wieselgren

Restricted diffusion of dopamine in the rat dorsal striatum

Apr 23, 2013·ACS Chemical Neuroscience·I Mitch TaylorAdrian C Michael

Classics in chemical neuroscience: clozapine

Sep 21, 2013·ACS Chemical Neuroscience·Cody J Wenthur, Craig W Lindsley

Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives

Sep 6, 2011·Journal of Medicinal Chemistry·Dina RobaaJochen Lehmann

Polypharmacology - foe or friend?

Aug 8, 2013·Journal of Medicinal Chemistry·Jens-Uwe Peters

Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs

Apr 14, 1977·Nature·F A HennA Sellström

A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood

Nov 10, 1977·Nature·I Creese, S H Snyder

Serotonergic component of neuroleptic receptors

Mar 9, 1978·Nature·J E LeysenP M Laduron

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

Aug 31, 1978·Nature·T LeeO Hornykeiwicz

Pharmacology. The dopamine connection

Sep 13, 1990·Nature·S H Snyder

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Sep 13, 1990·Nature·P SokoloffJ C Schwartz

D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats

Aug 9, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nathalie GinovartShitij Kapur

The role of imaging in proof of concept for CNS drug discovery and development

Oct 10, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dean F WongGerhard Gründer

A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia

May 13, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kathryn M GillAnthony A Grace

D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors

Feb 21, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cecilie Bay-RichterPaula M Moran

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

Feb 14, 2009·Nature Reviews. Drug Discovery·Gerhard GründerArvid Carlsson

Blockade of phencyclidine-induced effects by a nitric oxide donor

Jul 6, 2000·British Journal of Pharmacology·M Bujas-BobanovicS M Dursun

Serine racemase binds to PICK1: potential relevance to schizophrenia

Nov 30, 2005·Molecular Psychiatry·K FujiiAkira Sawa

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ronan DepoortèreBernard Scatton

SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug

May 20, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew C McCrearyChris Kruse

Dopamine and serotonin receptor binding and antipsychotic efficacy

Jan 26, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Neil M RichtandRobert K McNamara

Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study

Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jiekun XuanLin He

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids

Jun 26, 2002·Journal of Clinical Pharmacy and Therapeutics·Anne Schock CitverRobert B Raffa

Basic mechanisms of psychotropic drugs

Mar 21, 2002·Epilepsia·Ulrich Ebert

Schizophrenia

Nov 3, 1977·The New England Journal of Medicine·R J Bladessarini

Schizophrenia

Jan 4, 1996·The New England Journal of Medicine·John M Kane

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics

Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Bernard MasriMarc G Caron

Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug

Dec 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·P SeemanK Wong

New detection of brain dopamine receptors with (3H)dihydroergocryptine

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·M TittlerP Seeman

Multiple receptors for brain dopamine

Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M TitelerP Seeman

Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride

Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M S LidowR B Innis

Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics

Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Kalpana Merchant, D M Dorsa

Differential expression of autoreceptors in the ascending dopamine systems of the human brain

Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·J H Meador-WoodruffS J Watson

Reality of auditory verbal hallucinations

Jul 22, 2009·Brain : a Journal of Neurology·Tuukka T RaijRiitta Hari

Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning

Sep 15, 2007·Cerebral Cortex·Marina V FrantsevaZafiris Daskalakis

A network of dopaminergic gene variations implicated as risk factors for schizophrenia

Nov 30, 2007·Human Molecular Genetics·Michael E TalkowskiVishwajit L Nimgaonkar

Dopamine genes and schizophrenia: case closed or evidence pending?

Jul 17, 2007·Schizophrenia Bulletin·Michael E TalkowskiVishwajit L Nimgaonkar

The dopamine hypothesis of schizophrenia: version III--the final common pathway

Mar 28, 2009·Schizophrenia Bulletin·Oliver D Howes, Shitij Kapur

Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis

Dec 14, 2011·Schizophrenia Bulletin·Kao Chin ChenElvira Bramon

Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings

Nov 17, 2001·Behavioural Pharmacology·L P KestlerE M Vega

Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses

Apr 19, 2003·International Clinical Psychopharmacology·Stéphane PotvinJean-Yves Roy

Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients

Jul 16, 2008·Pharmacogenetics and Genomics·Bo GuQing-He Xing

The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders

Sep 17, 2002·Genes & Development·Annie AndrieuxDidier Job

Acute endocrine profile of sulpiride in the human

Sep 1, 1978·Clinical Endocrinology·M L'HermiteC Robyn

Visuo-motor reaction times of normal subjects and schizophrenics using inverting prisms

Jun 1, 1989·The Japanese Journal of Psychiatry and Neurology·H NinomiyaT Ikeda

A study of clinical response to different kinds of neuroleptics in first time medicated schizophrenics

Mar 1, 1992·The Japanese Journal of Psychiatry and Neurology·K Kadota

Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo

Mar 1, 1993·The Japanese Journal of Psychiatry and Neurology·Tomiki SumiyoshiF Ichimura

A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit

Mar 1, 1994·The Japanese Journal of Psychiatry and Neurology·H Maeda

The functional role of mesotelencephalic dopamine systems

Nov 1, 1992·Biological Reviews of the Cambridge Philosophical Society·Stephen B Dunnett, T W Robbins

Alpha 4-2 beta 2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs

Mar 1, 1992·British Journal of Pharmacology·J ConnollyS F Heinemann

Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test

Jul 1, 1994·British Journal of Pharmacology·Eric P M PrinssenA R Cools

Functional dopamine D2 receptors on rat vagal afferent neurones

Apr 1, 1995·British Journal of Pharmacology·A J LawrenceB Jarrott

Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion

Feb 1, 1979·Acta Psychiatrica Scandinavica·S LalH Guyda

Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage

Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·P Seeman

Distribution of remoxipride to the human brain and central D2-dopamine receptor binding examined in vivo by PET

Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·L Farde, C von Bahr

A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation

Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·Guy Chouinard

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia

Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·G P Reynolds

New drugs for the treatment of schizophrenic patients

Jan 1, 1995·Acta Psychiatrica Scandinavica. Supplementum·W W Fleischhacker

Abnormal neural integration related to cognition in schizophrenia

May 4, 1999·Acta Psychiatrica Scandinavica. Supplementum·R J DolanC D Frith

Binding of [3H]SCH 39166 to human post mortem brain tissue

Mar 1, 1993·Pharmacology & Toxicology·H HallG Sedvall

Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents

Sep 1, 1994·Pharmacology & Toxicology·A LangE Vasar

Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies

Jul 23, 1999·Annals of the New York Academy of Sciences·J EpsteinD Silbersweig

3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing

Jul 1, 1978·The Journal of Pharmacy and Pharmacology·S GovoniM Trabucchi

The effect of 2-substitution on conformations and brain concentrations of phenothiazine-neuroleptics in relation to dopamine-antagonism

Oct 1, 1979·The Journal of Pharmacy and Pharmacology·C J GrolH W Asselbergs

Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum

Nov 1, 1992·The Journal of Pharmacy and Pharmacology·H TsuchihashiT Nagatomo

The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration

May 25, 2011·The Journal of Pharmacology and Experimental Therapeutics·A B NormanRonald W Millard

Molecular pathology of schizophrenia: more than one disease process?

Jan 12, 1980·British Medical Journal·T J Crow

Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

Oct 29, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·N J DaveyP H Ellaway

Etiopathogenesis and treatment of psychosis

Jan 1, 1994·Annual Review of Medicine·T J Crow, C A Harrington

Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment

Feb 22, 2008·Journal of Neurophysiology·Dorea Vierling-ClaassenNancy Kopell

Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients

Nov 13, 2004·Neuropsychobiology·Matthias VogelIngolf Cascorbi

Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer

Oct 2, 2012·American Journal of Respiratory and Critical Care Medicine·Chi-Tai YehChi-Ying F Huang

Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio

Jun 26, 2012·BMC Pharmacology·Somayeh JafariFrancesca Fernandez-Enright

Predictions of in vivo prolactin levels from in vitro K(i) values of D(2) receptor antagonists using an agonist-antagonist interaction model

Feb 9, 2013·The AAPS Journal·Klas J PeterssonLena E Friberg

Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Dec 12, 2012·The Journal of Experimental Biology·Joanne P WebsterGlenn A McConkey

Analysis of neuronal functions in mice lacking the NMDA receptor epsilon 1 subunit

Jul 2, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yoshiaki Miyamoto, Toshitaka Nabeshima

The d-1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour

Apr 1, 1987·Reviews in the Neurosciences·John L Waddington, K M O'Boyle

Developing therapeutics for schizophrenia and other psychotic disorders

Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Gerard J Marek, Kalpana Merchant

New atypical antipsychotics for schizophrenia: iloperidone

Apr 7, 2010·Drug Design, Development and Therapy·Silvio CacciaAlessandro Nobili

Critical appraisal of lurasidone in the management of schizophrenia

May 10, 2012·Neuropsychiatric Disease and Treatment·Silvio CacciaAlessandro Nobili

Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies

Oct 3, 2001·CNS Drugs·Johannes Tauscher, Shitij Kapur

Dopamine partial agonists: a new class of antipsychotic

Mar 16, 2004·CNS Drugs·Jeffrey A Lieberman

Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors

Jun 21, 2007·CNS Drugs·José A Apud, Daniel R Weinberger

Distinguishing the voice of self from others: the self-monitoring hypothesis of auditory hallucination

Sep 18, 2010·Shinrigaku kenkyu : The Japanese journal of psychology·Tomohisa Asai, Yoshihiko Tanno

Chemical brain anatomy in schizophrenia

Sep 16, 1995·Lancet·G Sedvall, L Farde

Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia

Jan 28, 2014·Schizophrenia Bulletin·Kathryn M GillAnthony A Grace

How have developments in molecular imaging techniques furthered schizophrenia research?

Jan 19, 2011·Imaging in Medicine·Judy L ThompsonAnissa Abi-Dargham

Clozapine, a fast-off-D2 antipsychotic

Nov 14, 2013·ACS Chemical Neuroscience·P Seeman

Prospects for pharmacotherapy of schizophrenia

Mar 4, 1995·Lancet·D Pickar

Effect of atypical antipsychotics on fetal growth: is the placenta involved?

Aug 1, 2012·Journal of Pregnancy·Sandeep RahaAlison C Holloway

Beyond dopamine: glutamate as a target for future antipsychotics

Jul 26, 2012·ISRN Pharmacology·Kyra-Verena SendtDerek K Tracy

Schizophrenia: more dopamine, more D2 receptors

Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·P Seeman, Shitij Kapur

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia

Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·G D HoneyT Sharma

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice

Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M R AdamsG Stanley McKnight

Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats

Jun 17, 2014·Pharmacology, Biochemistry, and Behavior·Michael De SantisChao Deng

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Mar 1, 1996·Psychopharmacology·A SchotteJ E Leysen

A specific effect of antipsychotic drugs on protein synthesis in human lymphomononuclear cells

Jun 1, 1990·Journal of Neurochemistry·Vishwajit L Nimgaonkar, S A Whatley

Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor

Jan 1, 1992·Journal of Neurochemistry·J J BillingsH F Kung

Analysis of the structure and expression of the human dopamine D2A receptor gene

Mar 1, 1991·Journal of Neurochemistry·K Y GandelmanK L O'Malley

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

Oct 1, 1992·Journal of Neurochemistry·L L DevaudB R Cooper

Revision of the classical dopamine D2 agonist pharmacophore based on an integrated medicinal chemistry, homology modelling and computational docking approach

Jul 25, 2014·Neurochemical Research·N Krogsgaard-LarsenT Balle

The chlorpromazine enigma

Jan 18, 2013·Journal of the History of the Neurosciences·Alan A Baumeister

History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia

Jan 18, 2013·Journal of the History of the Neurosciences·Bertha K Madras

Catecholamine-sensitive adenylate cyclases in nervous tissues

Jul 1, 1977·Journal of Neurochemistry·L L Iversen

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

Jun 1, 1992·Journal of Neurochemistry·J Ichikawa, H Y Meltzer

Schizophrenia: genesis of a complex disease

Jul 25, 2014·Nature·Jonathan Flint, Marcus Munafò

A radioreceptor assay for neuroleptic drugs in plasma

Jan 1, 1980·Journal of Immunoassay·S R Lader

White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia

Jan 1, 2011·Schizophrenia Research and Treatment·Haiyun Xu, Xin-Min Li

Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders

Sep 9, 1996·Journal of Affective Disorders·H MankiM Asai

Sleep quality in schizophrenia and the effects of atypical antipsychotic medication

Dec 1, 2004·Acta Neuropsychiatrica·P M Judith HaffmansAndreas Schreiner

No change in dopamine D1 receptor in vivo binding in rats after sub-chronic haloperidol treatment

Mar 26, 2002·Canadian Journal of Physiology and Pharmacology·Vito SanciJean N DaSilva

PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects

Apr 13, 2000·Neuropharmacology·H C AkunneT A Pugsley

Antiparkinsonian drug doses and neuroleptic receptors

Nov 15, 1978·Experientia·M Titeler, P Seeman

In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats

Aug 26, 1999·Neuropharmacology·S ChakiK Tomisawa

Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo

Sep 1, 1991·Neuropharmacology·T A Patterson, J O Schenk

Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain

Nov 1, 1988·Neuropharmacology·C N SvendsenE D Bird

The use of atypical antipsychotics in traumatic brain injury

Jun 13, 2003·The Journal of Head Trauma Rehabilitation·Elie Paul ElovicJoseph H Ricker

Neuroreceptor imaging studies in schizophrenia

Oct 10, 2007·Harvard Review of Psychiatry·W Gordon Frankle

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

Mar 29, 2001·Journal of Clinical Psychopharmacology·X XiberasM L Paillère-Martinot

The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study

Feb 24, 1998·Journal of Clinical Psychopharmacology·G RemingtonRobert B Zipursky

Amoxapine as an antipsychotic: comparative study versus haloperidol

Nov 16, 2007·Journal of Clinical Psychopharmacology·Imran B ChaudhryShitij Kapur

Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial

Dec 27, 2011·Journal of Clinical Psychopharmacology·Gary RemingtonNaima Javaid

Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis

Apr 24, 2013·Journal of Clinical Psychopharmacology·M IyoKenji Hashimoto

D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics

Jul 23, 1999·Annals of the New York Academy of Sciences·J N Joyce, E V Gurevich

An increase in [3H] CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics

Oct 10, 1998·Brain Research·A Kurumaji, M Toru

3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects

Feb 1, 1992·Biological Psychiatry·N WodarzP Riederer

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients

Apr 1, 1988·Biological Psychiatry·M SmithA Wolkin

Chemistry, physiology and neuropsychology of schizophrenia: towards an earlier diagnosis of schizophrenia I

Jan 1, 1983·Archiv für Psychiatrie und Nervenkrankheiten·H H Kornhuber

Pathophysiology of schizophrenia - causal role for dopamine or noradrenaline?

Oct 13, 1983·Nature·L L IversenS H Snyder

Adult mice with reduced Nurr1 expression: an animal model for schizophrenia

Apr 26, 2007·Molecular Psychiatry·P RojasS O Ogren

Towards a muscarinic hypothesis of schizophrenia

Dec 6, 2006·Molecular Psychiatry·T J RaedlerB Dean

Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients

Jan 23, 2002·American Journal of Medical Genetics·Y H ChenC H Chen

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

Apr 17, 2001·American Journal of Medical Genetics·H HoriJ Nakamura

Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia

Sep 5, 2002·American Journal of Medical Genetics·Hong-Seock LeeSangduk Kim

Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia

Mar 15, 1994·American Journal of Medical Genetics·S ShaikhD Collier

Lack of association between dopamine D4 receptor gene and schizophrenia

Dec 18, 1995·American Journal of Medical Genetics·T TanakaS Ihda

SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors

May 20, 1985·Life Sciences·D W SchulzRichard B Mailman

Neurochemical psychiatry as a source of hypotheses concerning the role of homeostatic mechanisms in brain function

Nov 1, 1984·The International Journal of Neuroscience·J S Richardson

Targeting the dopamine D2 receptor in schizophrenia

Jul 20, 2006·Expert Opinion on Therapeutic Targets·P Seeman

Schizophrenia endophenotypes as treatment targets

Sep 12, 2007·Expert Opinion on Therapeutic Targets·Gunvant K Thaker

Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia

Aug 13, 2008·Expert Opinion on Therapeutic Targets·Shinsuke Matsuzaki, Masaya Tohyama

Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials

Dec 21, 2013·Expert Opinion on Pharmacotherapy·Naren P Rao, Gary Remington

Possible dose-side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophrenia

Nov 1, 2008·Expert Review of Clinical Pharmacology·Tomiki Sumiyoshi

Trazodone: properties and utility in multiple disorders

Nov 26, 2011·Expert Review of Clinical Pharmacology·Aravind Mittur

Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment

Apr 8, 2011·Expert Review of Neurotherapeutics·Gary RemingtonGeorge Foussias

Rationale for current therapies in Parkinson's disease

Oct 3, 2003·Expert Opinion on Pharmacotherapy·Janet RomrellMichael S Okun

Discontinued drugs in 2005: schizophrenia drugs

Nov 17, 2006·Expert Opinion on Investigational Drugs·R W Kerwin

Serotonin 2A receptor antagonists for treatment of schizophrenia

Jul 12, 2011·Expert Opinion on Investigational Drugs·Bjørn H EbdrupBirte Glenthøj

Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity

Aug 1, 2009·Expert Opinion on Drug Discovery·Gianluca NucciItalo Poggesi

Drug discovery paradigms: past, present, future - a centennial symposium of the American Society for Pharmacology and Experimental Therapeutics

Sep 1, 2008·Expert Opinion on Drug Discovery·Icilio Cavero, Harvey R Kaplan

Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials

May 4, 2013·Expert Opinion on Investigational Drugs·Naren P Rao, Gary Remington

The pharmacology and toxicology of atypical antipsychotic agents

May 1, 2001·Journal of Toxicology. Clinical Toxicology·M J Burns

Molecular attributes of dopamine receptors: new potential for antipsychotic drug development

Jun 1, 1996·Annals of Medicine·D S Hartman, O Civelli

Dopamine in schizophrenia

Dec 1, 1996·Annals of Medicine·J Hietala, E Syvälahti

Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors

Dec 3, 2013·Archives of Physiology and Biochemistry·Mahmut ErzenginNahit Gencer

The distribution of a dopamine D2 receptor mRNA in rat brain

Aug 14, 1989·FEBS Letters·D M Weiner, M R Brann

Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences

Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·H J Möller

Treatment of psychosis: 30 years of progress

Dec 21, 2006·Journal of Clinical Pharmacy and Therapeutics·I R De Oliveira, M F Juruena

Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia

Oct 2, 2014·Brain Structure & Function·Matthew W RiceEmma Perez-Costas

Antipsychotic medications, glutamate, and cell death: a hidden, but common medication side effect?

Dec 26, 2012·Medical Hypotheses·Amanda M IsomNeil M Richtand

In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor

Dec 15, 2015·Molecular Pharmacology·Martyn WoodMichel Gillard

Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling

Apr 24, 2014·The European Journal of Neuroscience·Mark J FerrisAmy J Ramsey

Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum

Jan 15, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G NovakSusan R George

Schizophrenia

Jan 19, 2016·Lancet·Michael J OwenPreben B Mortensen

Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis

Jul 17, 2012·Schizophrenia Research·Zeynep YilmazZafiris Daskalakis

Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D₁ receptor

Jul 4, 2012·Bioorganic & Medicinal Chemistry·Wangke QianHong Liu

Intervention, causal reasoning, and the neurobiology of mental disorders: Pharmacological drugs as experimental instruments

Apr 24, 2012·Studies in History and Philosophy of Biological and Biomedical Sciences·Jonathan Y Tsou

Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database

Feb 24, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sanghyeon KimMaree J Webster

Emergency pharmacotherapy of delirium in the critically ill cancer patient

Jan 1, 1986·Psychosomatics·F AdamsB S Andersson

Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys

Dec 9, 2015·The Journal of Pharmacology and Experimental Therapeutics·Robert E BrutcherMichael A Nader

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia

Dec 6, 2011·Neuropharmacology·Daniela AlberatiJoseph G Wettstein

Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics

Aug 20, 2014·ACS Chemical Biology·Hyekyung P ChoCraig W Lindsley

Synapsin III: role in neuronal plasticity and disease

Aug 11, 2011·Seminars in Cell & Developmental Biology·Barbara PortonHung-Teh Kao

Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience

Feb 23, 2011·Behavioural Processes·Ryan D WardPeter D Balsam

Infralimbic D2 receptors are necessary for fear extinction and extinction-related tone responses

Oct 12, 2010·Biological Psychiatry·Devin MuellerGregory J Quirk

Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse

Sep 8, 2010·Neuroscience·G S DaweA K Ratty

The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine

Oct 5, 2010·Brain Research·Pawel MatulewiczMark Jeremy Hunt

New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders

Dec 1, 2015·Pharmacology & Therapeutics·Giuseppe Di Giovanni, Philippe De Deurwaerdère

Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice

Jul 6, 2010·Brain Research Bulletin·Francisca Charliane Carlos da SilvaFrancisca Cléa Florenço de Sousa

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response

Dec 17, 2015·Pharmacogenomics·Eric HuangJames L Kennedy

The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties

Nov 19, 2009·European Journal of Pharmacology·Tino DyhringNicholas Waters

DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness

Nov 26, 2011·ACS Chemical Neuroscience·Dinesh C SoaresDavid J Porteous

Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif

Oct 3, 2009·Bioorganic & Medicinal Chemistry Letters·Laura CarroChristian F Masaguer

Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review

Aug 5, 2009·Neuroscience and Biobehavioral Reviews·Dragos IntaPeter Gass

Effects of antipsychotic drugs on brain-stimulation detection: preliminary observations

Oct 1, 1984·Pharmacology, Biochemistry, and Behavior·H S Wheeling, C Kornetsky

The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors

Jun 23, 2009·Pharmacology, Biochemistry, and Behavior·Changjiu Zhao, Ming Li

Gestational treatment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine

May 27, 2009·Pharmacology, Biochemistry, and Behavior·R E FeatherstoneP J Fletcher

A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects

Dec 1, 2014·Neuron·Ping SuFang Liu

Discovery of GlyT1 inhibitors with improved pharmacokinetic properties

Feb 3, 2009·Bioorganic & Medicinal Chemistry Letters·Scott E WolkenbergGeorge D Hartman

Biomarkers in psychotropic drug development

Nov 13, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Saeeduddin AhmedWilliam Z Potter

Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups

Jan 22, 2009·Bioorganic & Medicinal Chemistry·Donald M N SikazweSeth Y Ablordeppey

Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders

Oct 17, 2008·Psychiatry Research·Amalia LafuenteXavier Carne

Analysis of binding residues between scorpion neurotoxins and D2 dopamine receptor: a computational docking study

Sep 19, 2008·Computers in Biology and Medicine·C SudandiradossRao Sethumadhavan

A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part II

Jul 16, 2008·Psychosomatics·Jose de LeonKelly L Cozza

Schizotypal personality traits and prediction of one's own movements in motor control: what causes an abnormal sense of agency?

Jun 3, 2008·Consciousness and Cognition·Tomohisa AsaiYoshihiko Tanno

Serotonergic approaches in the development of novel antipsychotics

Jul 16, 2008·Neuropharmacology·Caitlin A Jones, Andrew C McCreary

Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one

Jul 4, 2008·Bioorganic & Medicinal Chemistry·Seth Y AblordeppeyBryan L Roth

Investigations on the interactions of scorpion neurotoxins with the predicted structure of D1 dopamine receptor by protein-protein docking method. A bioinformatics approach

Jun 19, 2008·Comptes rendus biologies·C SudandiradossRao Sethumadhavan

A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I

May 2, 2008·Psychosomatics·Jose de LeonKelly L Cozza

Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study

Dec 22, 2007·Psychiatry Research·Georg JuckelEva-Maria Meisenzahl

In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding

Aug 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S M MoerleinM J Welch

1-Aminoindanes as novel motif with potential atypical antipsychotic properties

Dec 28, 2007·Bioorganic & Medicinal Chemistry Letters·James M GrahamSham S Nikam

The role of cortical inhibition in the pathophysiology and treatment of schizophrenia

Nov 6, 2007·Brain Research Reviews·Zafiris DaskalakisBruce K Christensen

Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent

Sep 18, 2007·Bioorganic & Medicinal Chemistry·Ruchika ChakrabartyAnil K Saxena

No association between the DRD3 Ser9Gly polymorphism and schizophrenia

Aug 19, 2007·Schizophrenia Research·Ferid FathalliRidha Joober

The amphetamine-induced sensitized state as a model of schizophrenia

Sep 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·R E FeatherstoneP J Fletcher

Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics

Jun 26, 2007·Bioorganic & Medicinal Chemistry Letters·María BarcelóMaría I Loza

Fifty years of dopamine research

Apr 3, 2007·Trends in Neurosciences·Anders Björklund, Stephen B Dunnett

Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling

Oct 31, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shaun JordanTetsuro Kikuchi

Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine

Oct 19, 2006·Biological Psychiatry·Houman Homayoun, Bita Moghaddam

Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia

Sep 29, 2004·Synapse·Raina M RogozaR K Mishra

The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats

Sep 8, 2005·Journal of Neurochemistry·H AlimohamadW J Rushlow

Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol

Aug 13, 2004·The European Journal of Neuroscience·Kerstin HåkanssonGilberto Fisone

The dorsal raphe nucleus in schizophrenia: a post mortem study of 5-hydroxytryptamine neurones

May 12, 2005·Neuropathology and Applied Neurobiology·R M CravenM M Esiri

Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics

Jul 22, 2005·Journal of Neurochemistry·W J RushlowN Rajakumar

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples

Oct 22, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Michael E TalkowskiVishwajit L Nimgaonkar

Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration

Sep 13, 2003·Journal of Neurochemistry·Wendy H Fasulo, Scott E Hemby

Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine

Aug 14, 2003·Scandinavian Journal of Psychology·Ola GefvertJoakim Tedroff

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

Mar 23, 2004·Synapse·Lilly SchwielerSophie Erhardt

Psychosis pathways converge via D2high dopamine receptors

Jun 21, 2006·Synapse·P SeemanTomiki Sumiyoshi

A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride

Sep 20, 2008·CNS Neuroscience & Therapeutics·Jennifer L Martelle, Michael A Nader

Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides

Aug 12, 2006·ChemMedChem·Craig W LindsleyGeorge D Hartman

Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression

Oct 26, 2005·Synapse·G NovakTeresa Tallerico

Synthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273

Feb 7, 2009·ChemMedChem·Darren W EngersCraig W Lindsley

Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine

May 23, 2006·Synapse·Françoise KoP Seeman

Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia

Aug 14, 2008·Acta Psychiatrica Scandinavica·K J LeeJ S Kwon

Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects

Nov 5, 2005·Synapse·Taylor Moran-GatesFrank I Tarazi

Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells

Jul 18, 2008·Journal of Neurochemistry·Peethambaran ArunAryan M A Namboodiri

Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats

Aug 19, 2007·British Journal of Pharmacology·W Dimpfel

Identification of drugs inducing phospholipidosis by novel in vitro data

Sep 5, 2012·ChemMedChem·Markus MuehlbacherJohannes Kornhuber

All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors

Jun 22, 2010·CNS Neuroscience & Therapeutics·P Seeman

Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects

May 11, 2011·Biomedical Chromatography : BMC·Theo de BoerHolger Lass

Alzheimer's disease: β-amyloid plaque formation in human brain

Jun 3, 2011·Synapse·P Seeman, Neil Seeman

Antipsychotic occupancy of dopamine receptors in schizophrenia

Dec 15, 2010·CNS Neuroscience & Therapeutics·Magdalena Nord, L Farde

Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects

Nov 23, 2011·Journal of Neurochemistry·Somayeh JafariXu-Feng Huang

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies

Jan 22, 2010·Journal of Neurochemistry·Emma Perez-CostasRosalinda C Roberts

The synapse in schizophrenia

Apr 10, 2014·The European Journal of Neuroscience·Andrew J PocklingtonMichael J Owen

Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain

Jun 15, 1979·Brain Research·N KlemmM J Kuhar

Traditional Chinese medicine and Western psychopharmacology: building bridges

Feb 19, 2013·Phytotherapy Research : PTR·Edward Shorter, Kathryn Segesser

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

Mar 26, 2016·Progress in Neurobiology·Philippe De Deurwaerdère, Giuseppe Di Giovanni

Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats

Jul 17, 2010·Brain Research·Takashi UeharaMasayoshi Kurachi

Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats

Feb 1, 2005·Pharmacology, Biochemistry, and Behavior·Keita IshiwariJohn D Salamone

The neural basis of hallucinations and delusions

Mar 18, 2005·Comptes rendus biologies·C D Frith

Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor

Sep 1, 1991·Genomics·G SarkarS S Sommer

Phenothiazine antagonism of calmodulin: a structurally-nonspecific interaction

Feb 12, 1981·Biochemical and Biophysical Research Communications·B D Roufogalis

Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility

Jan 1, 1992·Genomics·J L SobellS S Sommer

Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics

Jan 1, 1986·Biological Psychiatry·N R SwerdlowG F Koob

Testosterone-mediated modulation of HERG blockade by proarrhythmic agents

May 30, 2001·Biochemical Pharmacology·Y M ShubaR L Woosley

Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain

Nov 9, 2004·Neuroscience Letters·Adalisa ReinkeJoão Quevedo

N-methyl-D-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking

Sep 15, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Edward F DominoHideo Tsukada

Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment

Oct 27, 2004·Medical Hypotheses·Shih-Jen Tsai

Opiate receptors and beyond: 30 years of neural signaling research

Oct 7, 2004·Neuropharmacology·Solomon H Snyder

Changes in proton T1 in dog brains due to the administration of haloperidol

Jan 1, 1987·Magnetic Resonance Imaging·T FujimotoT Asakura

Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia

Sep 16, 1985·Brain Research·D B LozovskyC F Saller

Interfaces between medicine and psychiatry

Jan 1, 1979·Comprehensive Psychiatry·L Eisenberg

Adrenergic crisis from crack cocaine ingestion: report of five cases

Jul 1, 1994·The Journal of Emergency Medicine·K S MerigianR Giometi

Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia

Apr 15, 2004·Life Sciences·B DeanD L Copolov

A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors

Jun 1, 1981·Pharmacological Research Communications·S Varmuza, R K Mishra

Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides

Sep 22, 2006·Bioorganic & Medicinal Chemistry Letters·Zhijian ZhaoCraig W Lindsley

Monoclonal antibodies with high affinity for spiroperidol

Apr 1, 1988·Journal of Neurochemistry·R R LuedtkeP B Molinoff

Dopamine receptors and the dopamine hypothesis of schizophrenia

Jan 1, 1987·Synapse·P Seeman

Ergopeptine-sensitive calcium-dependent protein phosphorylation system in the brain

Mar 1, 1984·Journal of Neurochemistry·C A StratfordT Ueda

Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats

May 1, 1983·Journal of Neurochemistry·M E Trulson, C D Himmel

Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients

Jan 1, 1988·Annals of the New York Academy of Sciences·D PickarJ Kelsoe

Neuroleptic binding to human brain receptors: relation to clinical effects

Jan 1, 1988·Annals of the New York Academy of Sciences·E Richelson

A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patients

Jan 1, 1981·Journal of Clinical Pharmacology·A A KurlandK T Ng

The dopamine radioreceptor assay--a clinical application

Oct 1, 1980·Journal of Clinical Pharmacology·A A KurlandT E Hanlon

The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra

Apr 1, 1984·British Journal of Pharmacology·R D Pinnock

Fall and rise of behavioural pharmacology

Jul 1, 2006·Drug Discovery Today. Technologies·Joop S de Graaf

In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors

May 30, 2006·European Journal of Pharmacology·Shaun JordanTetsuro Kikuchi

Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender

Apr 4, 2006·Biological Psychiatry·Birte Y GlenthojCharlotte Videbaek

Acute D2/D3 dopaminergic agonism but chronic D2/D3 antagonism prevents NMDA antagonist neurotoxicity

Apr 18, 2006·Biological Psychiatry·Nuri B FarberKevin K Noguchi

Dopamine D3 receptor and schizophrenia: a widened scope for the immune hypothesis

Mar 17, 2006·Medical Hypotheses·Matthias VogelHans Jörgen Grabe

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

Mar 24, 2006·European Journal of Pharmacology·Cristina CosiAdrian Newman-Tancredi

Academic psychiatry and the pharmaceutical industry

Jan 31, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Thomas A Ban

Classification of dopamine, serotonin, and dual antagonists by decision trees

Jan 3, 2006·Bioorganic & Medicinal Chemistry·Hye-Jung KimAe Nim Pae

Investigating principles of human brain function underlying working memory: what insights from schizophrenia?

Dec 14, 2005·Neuroscience·G D Honey, P Fletcher

The involvement of G proteins and regulators of receptor-G protein coupling in the pathophysiology, diagnosis and treatment of mood disorders

Dec 13, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sofia Avissar, Gabriel Schreiber

Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable

Dec 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rossella MedoriGerhard Gründer

Tyrosine transport in fibroblasts from healthy volunteers and patients with schizophrenia

Nov 9, 2005·Neuroscience Letters·Emma OlssonNikolaos Venizelos

Classification of dopamine antagonists using functional feature hypothesis and topological descriptors

Nov 1, 2005·Bioorganic & Medicinal Chemistry·Hye-Jung KimAe Nim Pae

Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure

Oct 4, 2005·Molecular and Cellular Neurosciences·Xun WangZhen Yan

Implications for reactive oxygen species in schizophrenia pathogenesis

Nov 22, 2015·Schizophrenia Research·Minori KogaThomas W Sedlak

Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study

Jul 19, 2005·Biological Psychiatry·Daphne J HoltJoel E Kleinman

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia

Jun 21, 2005·Neuroscience and Biobehavioral Reviews·Urs MeyerBenjamin K Yee

Pathway-Specific Dopamine Abnormalities in Schizophrenia

May 22, 2016·Biological Psychiatry·Jodi J WeinsteinAnissa Abi-Dargham

Schizophrenia, psychosis, and the basal ganglia

Jan 27, 1998·The Psychiatric Clinics of North America·G F Busatto, R W Kerwin

Emerging roles for novel antipsychotic medications in the treatment of schizophrenia

Apr 29, 1998·The Psychiatric Clinics of North America·C AnderssonJeffrey A Lieberman

Does clozapine work by blocking spikes and sparing bursts?

May 17, 2005·Medical Hypotheses·Timothy P Olson

Separate serotonin and dopamine receptors modulate the duration of post-tetanic potentiation at an Aplysia synapse without affecting other aspects of synaptic transmission

Jan 6, 1980·Brain Research·S A NewlinS H Barondes

Heterosynaptic stimulation modulates the duration of post-tetanic potentiation at an Aplysia synapse without affecting other aspects of synaptic transmission

Jan 6, 1980·Brain Research·S A NewlinS H Barondes

Interaction of hydrophobic organic compounds with mercury adsorbed dioleoylphosphatidylcholine monolayers

Jan 29, 1990·Biochimica Et Biophysica Acta·A NelsonJ Borlakoglu

The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain

Apr 24, 1995·Brain Research·L A ShapiroG A Ordway

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

May 31, 1988·Brain Research·S F CalderonA B Norman

Ontogenesis of dopamine receptor binding in the corpus striatum of the rat

Apr 15, 1977·Brain Research·J V PardoS H Snyder

Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol

Nov 13, 1992·Brain Research·B R Shivakumar, V Ravindranath

Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies

May 14, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rae PriceTarek K Rajji

Dopamine: the rewarding years

Jan 13, 2006·British Journal of Pharmacology·Charles A Marsden

Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics

Dec 29, 2006·Chemistry & Biodiversity·Mario AlvaradoEnrique Raviña

Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia

Aug 19, 2015·Biological Psychiatry·Monika P JadiTerrence J Sejnowski

Selection in the dopamine receptor 2 gene: a candidate SNP study

Aug 21, 2015·PeerJ·Tobias Göllner, Martin Fieder

The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways

Mar 8, 2013·Neuropharmacology·Hannah K DelilleGerard J Marek

Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese

May 10, 2012·Neuroscience Letters·Chunming ZhengQi Xu

Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold

Nov 13, 2012·Bioorganic & Medicinal Chemistry Letters·Alice L RodriguezShaun R Stauffer

Antipsychotic dose and diminished neural modulation: a multi-site fMRI study

Dec 28, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·C AbbottV D Calhoun

Synthesis and SAR study of diphenylbutylpiperidines as cell autophagy inducers

Dec 4, 2010·Bioorganic & Medicinal Chemistry Letters·Gang ChenChengye Yuan

Disposition of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic, in the rat on repeated oral dosage

Oct 1, 1981·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K SudoM Sano

Antipsychotic drugs on maternal behavior in rats

Jul 30, 2015·Behavioural Pharmacology·Ming Li

Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis

Mar 5, 2016·Current Opinion in Behavioral Sciences·Gary GilmourMark E Walton

Using human brain imaging studies as a guide toward animal models of schizophrenia

Jun 4, 2015·Neuroscience·S S BolkanChristoph Kellendonk

Dopamine D2 receptors as treatment targets in schizophrenia

Jul 21, 2010·Clinical Schizophrenia & Related Psychoses·P Seeman

Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders

Apr 4, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mark J MillanSven Ove Ögren

Facial emotion identification in early-onset psychosis

Dec 4, 2014·Schizophrenia Research·Sophie J BarklLeanne M Williams

Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future

Jul 27, 2010·Schizophrenia Research·Rajiv TandonMatcheri S Keshavan

Probabilistic learning and inference in schizophrenia

Sep 3, 2010·Schizophrenia Research·Bruno B AverbeckSukhwinder S Shergill

Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs

Jun 12, 2012·Neuron·Carsten H TischbirekTeja W Groemer

Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions

Feb 6, 2015·Molecular Diversity·Ramin Ekhteiari SalmasSerdar Durdagi

What are the optimal pharmacokinetic properties of antipsychotic medications?

Sep 8, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ung Gu Kang

Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole

Aug 30, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Beryl KoenerEmmanuel Hermans

Are dopamine D2 receptors out of control in psychosis?

Jul 25, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Seeman

Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task

Nov 19, 2013·Behavioural Brain Research·Daniel Scott, Jane R Taylor

Cholinergic depletion in the nucleus accumbens: effects on amphetamine response and sensorimotor gating

Dec 18, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·François LaplanteRon M Sullivan

Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia

Aug 21, 2013·Pharmacology, Biochemistry, and Behavior·Sania GroverR D Budhiraja

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

Sep 11, 1999·Cell·A R MohnB H Koller

Timing as a window on cognition in schizophrenia

May 3, 2011·Neuropharmacology·Ryan D WardPeter D Balsam

Neural response to experimental heat pain in stable patients with schizophrenia

Oct 1, 2011·Journal of Psychiatric Research·Camilo de la Fuente-SandovalAriel Graff-Guerrero

Drug development in schizophrenia: are glutamatergic targets still worth aiming at?

Feb 25, 2015·Current Opinion in Psychiatry·Donald C Goff

Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL

Dec 15, 2012·Cancer Cell·Daniel NagelDaniel Krappmann

Serotonin in antipsychotic drugs action

Aug 1, 2014·Behavioural Brain Research·Davide Amato

Serotonin: from sensory processing to schizophrenia using an electrophysiological method

Jun 28, 2014·Behavioural Brain Research·Georg Juckel

Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia

Jan 23, 2009·Biological Psychiatry·Yan WangYan Shen

γ oscillations in schizophrenia: mechanisms and clinical significance

Aug 16, 2011·Brain Research·Yinming SunZafiris Daskalakis

Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

Jan 29, 2011·European Journal of Pharmacology·Anders Fink-JensenDavid P D Woldbye

Breathing is affected by dopamine D2-like receptors in the basolateral amygdala

Oct 5, 2014·Respiratory Physiology & Neurobiology·Toshihisa SugitaMasahiko Izumizaki

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

Feb 13, 2001·Annual Review of Medicine·Shitij Kapur, Gary Remington

No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study

Oct 22, 2008·The International Journal of Neuropsychopharmacology·Hiroshi ItoT Suhara

Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children

Aug 30, 2014·Biological Psychiatry·Karrnan PathmanandavelFabienne Brilot

Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder

Apr 12, 2014·Frontiers in Psychiatry·Maria R DauvermannThomas W J Moorhead

Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?

Oct 31, 2014·Behavioural Pharmacology·B A Ellenbroek, Eric P M Prinssen

Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes

Apr 30, 2003·Diabetes Care·Michael E J Lean, Frank-Gerald Pajonk

Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia

Aug 19, 2010·Journal of Pharmacological Sciences·Masanari ItokawaM Toru

Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex

May 11, 2016·Neuropharmacology·Yan-Chun LiWen-Jun Gao

Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects

Jun 9, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Yuta YoshinoShu-Ichi Ueno

Neuroleptics: preclinical and clinical differences

Dec 1, 1992·Acta Neuropsychiatrica·B A Ellenbroek, A R Cools

The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands

Jul 2, 2016·Journal of Biomolecular Structure & Dynamics·Ramin Ekhteiari SalmasSerdar Durdagi

Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations

Jul 20, 2016·ACS Chemical Neuroscience·Geancarlo ZanattaCarmem Gottfried

Dopamine receptor pharmacology

Sep 24, 2008·Handbook of Clinical Neurology·Richard B Mailman, Xuemei Huang

When one's sense of agency goes wrong: Absent modulation of time perception by voluntary actions and reduction of perceived length of intervals in passivity symptoms in schizophrenia

Aug 22, 2016·Consciousness and Cognition·Kyran T Graham-SchmidtFlavie A V Waters

Structural Basis and Mechanism of Chiral Benzedrine Molecules Interacting With Third Dopamine Receptor

Sep 2, 2016·Chirality·Ming WangSichuan Xu